Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 7 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $745K 17.7K sh | Jan 13, 2026 |
| 6 | Farquhar ScottDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $65K 450 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 6 | Litinsky James H.Director, Chairman and CEO | Grant or award | A | — 38.2K sh | Jan 13, 2026 traded Jan 12, 2026 |
| 6 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $65K 450 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 6 | Farquhar ScottDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $213K 1,435 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 6 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $213K 1,435 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 6 | Patel AnishCHIEF OPERATING OFFICER | Open-market sale · 10b5-1 plan | SELL | $6,926 243 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 5 | Giordano Christopher ThomasDirector, CEO | Grant or award | A | — 450.0K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 5 | Taub RebeccaDirector | Option exercise · 10b5-1 plan | M | $291K 18.4K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 5 | Majalya Sidney A.SVP, CLO and Secretary | Open-market sale · 10b5-1 plan | SELL | $48K 775 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 5 | Brown Andrew William FraserDirector | Grant or award | A | — 1,076 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 5 | Yake AliceDirector | Grant or award | A | — 1,200 sh | Jan 13, 2026 traded Jan 10, 2026 |
| 5 | Hartz Joseph L.President of Subsidiary | Option exercise | M | — 4,390 sh | Jan 13, 2026 traded Jan 11, 2026 |
| 5 | Rich StuartDirector, Chief Medical Officer | Grant or award | A | — 250.0K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 5 | Truong KristinaChief Accounting Officer | Tax withholding | F | $2,233 282 sh | Jan 13, 2026 traded Jan 10, 2026 |
| 5 | Modi Rajeev A.SEE REMARKS | Grant or award | A | $1,415 60 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 5 | Bell Hans G.President of Subsidiary | Option exercise | M | — 3,310 sh | Jan 13, 2026 traded Jan 11, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $96K 2,265 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 4 | Benkowitz MichaelPRESIDENT AND COO | Option exercise · 10b5-1 plan | M | $1.72M 14.6K sh | Jan 13, 2026 traded Jan 12, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $392K 9,059 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 4 | Benkowitz MichaelPRESIDENT AND COO | Option exercise · 10b5-1 plan | M | $1.15M 7,875 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $703K 16.8K sh | Jan 13, 2026 traded Jan 13, 2026 |
| 4 | Dines DanielDirector, CEO and Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $773K 45.0K sh | Jan 13, 2026 traded Jan 13, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $303K 6,841 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 4 | Lee JanetGC & Corporate Secretary | Open-market sale · 10b5-1 plan | SELL | $133K 250 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 3 | Farquhar ScottDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $25K 169 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 3 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | — 2,170 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 3 | Benkowitz MichaelPRESIDENT AND COO | Option exercise · 10b5-1 plan | M | — 14.6K sh | Jan 13, 2026 traded Jan 12, 2026 |
| 3 | Benkowitz MichaelPRESIDENT AND COO | Option exercise · 10b5-1 plan | M | — 7,875 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 3 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $25K 170 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 1 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $82K 2,010 sh | Jan 13, 2026 traded Jan 13, 2026 |
| 1 | Rizik MatthewDirector | Open-market sale · 10b5-1 plan | SELL | $57K 2,500 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 1 | Rizik MatthewDirector | Open-market sale · 10b5-1 plan | SELL | $57K 2,500 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 1 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $173K 4,100 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 0 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $29K 685 sh | Jan 13, 2026 traded Jan 13, 2026 |
| 0 | Houston AndrewDirector, Chief Executive Officer, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 23.8K sh | Jan 13, 2026 traded Jan 12, 2026 |
| 0 | Houston AndrewDirector, Chief Executive Officer, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 23.8K sh | Jan 13, 2026 traded Jan 12, 2026 |
| 0 | Ahn KennethPresident, Hagerty Marketplace | Derivative conversion · 10b5-1 plan | C | — 50.0K sh | Jan 13, 2026 traded Jan 12, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | — 6,348 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | $6,856 6,348 sh | Jan 13, 2026 traded Jan 12, 2026 |